Your institution may have access to this item. Find your institution then sign in to continue.
Title
Oncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancer.
Authors
Sunaga, N; Kaira, K; Imai, H; Shimizu, K; Nakano, T; Shames, D S; Girard, L; Soh, J; Sato, M; Iwasaki, Y; Ishizuka, T; Gazdar, A F; Minna, J D; Mori, M